about
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...
Read More
14.00
0.28
(2.04%)
233.7K
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Board Meeting
The latest board meeting for GH Research PLC took place on 14 Nov 2025, for the purpose of GH Research PLC Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
GH Research PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..